I think your post is far from being over optimistic. The only issue for me is that brokers (Mr Market) will find it hard to understand the process and approach that PYC take in their drug development and therefore the very serious prospect of achieving a successful outcome for all of their drug candidates.
My apologies if you're a broker reading this post, you may well have far more medical expertise than I have and be quietly buying up the stock for your clients.
- Forums
- ASX - By Stock
- PYC
- Ann: Visual Improvement in Multiple RP11 Patients
Ann: Visual Improvement in Multiple RP11 Patients, page-6
-
-
- There are more pages in this discussion • 14 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PYC (ASX) to my watchlist
(20min delay)
|
|||||
Last
10.0¢ |
Change
-0.005(4.76%) |
Mkt cap ! $466.6M |
Open | High | Low | Value | Volume |
10.5¢ | 10.8¢ | 10.0¢ | $164.9K | 1.586M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 154875 | 11.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
9.7¢ | 39559 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
7 | 106279 | 0.105 |
13 | 758044 | 0.100 |
2 | 711139 | 0.099 |
5 | 185204 | 0.098 |
2 | 29485 | 0.097 |
Price($) | Vol. | No. |
---|---|---|
0.097 | 39559 | 2 |
0.100 | 48884 | 3 |
0.105 | 252364 | 4 |
0.110 | 175001 | 4 |
0.115 | 1260233 | 8 |
Last trade - 15.59pm 13/08/2024 (20 minute delay) ? |
Featured News
PYC (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Steven Gourlay, Managing Director and CEO
Steven Gourlay
Managing Director and CEO
SPONSORED BY The Market Online